Floatz logo

277 assets in Small Cell Lung Carcinoma

Therapeutic assets addressing Small Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Benmelstobart
Small Cell Lung Carcinoma
Yayi HeP4A (80)
Anti-Pd-L1 Monoclonal Antibody Shr-1316
Small Cell Lung Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.P3BBB (73)
Berzosertib
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P2BBB (73)
Cis-Diamminedichloroplatinum Ii
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P4BBB (72)
Etoposide
Small Cell Lung Carcinoma
Sichuan UniversityP4BBB (72)
Carboplatin
Small Cell Lung Carcinoma
University of Maryland, BaltimoreP4BB (71)
Veliparib
Small Cell Lung Carcinoma
Central European Society for Anticancer Drug ResearchP2BB (71)
hs-20093
Small Cell Lung Carcinoma
Shanghai Hansoh Biomedical Co., LtdP3BB (70)
Irinotecan
Small Cell Lung Carcinoma
Sichuan UniversityP4BB (70)
L-Kappa-H-Gamma1 (Knob) Chain Anti-Dll3 (1-705) [L-Kappa Anti-Dll3 (1-214) [V-Kappa (Homo Sapiens Igkv1-17*03 (94.9%) -Igkj2*01 (100%), Cdr-Imgt [6.3.9] (27-32.50-52.89-97)) (1-107) -Homo Sapiens Igkc*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')] -38-Mer (Ggggse Gkssgsgses Kstegkssgs Gseskstggggs) Linker (215-252) -H-Gamma-1 Heavy Chain Anti-Dll3 (253-705) [Vh (Homo Sapiens Ighv1-46*01 (92.9%) -(Ighd) -Ighj6*01 (94.7%), Cdr-Imgt [8.8.17] (278-285.303-310.349-365)) (253-376)-Homo Sapiens Ighg1*03, G1M3, Ng1M1, Ch1 R120, Ch3 E12, M14, G1V14 Ch2 A1.3, A1.2, G1V32 Ch3 W22 (Knob) (Ch1 R120 (473) (377-474), Hinge 1-15 (475-489), Ch2 L1.3>A (493), L1.2>A (494) (490-599), Ch3 E12 (615), M14 (617), T22>W (625) (600-704), Chs K2>Del (705)) (377-705)]]; L-Lambda6-H-Gamma1 (Hole) Chain Anti-Cd3E (1-707) [L-Lambda6 Anti-Cd3 (1'-215') [V-Lambda Musmus/Homsap (Mus Musculus Iglv1*01 (82.3%) -Iglj1*01 (100%)/Homo Sapiens Iglv7-46*01 (76.8%) -Iglj3*02 (100%), Cdr-Imgt [9.3.9] (26'-34'.52'-54'.91'-99')) (1'-109') -Homo Sapiens Iglc6*01 (100%) (110'-215')] -38-Mer (Ggggse Gkssgsgses Kstegkssgsgseskstggggs) Linker (216'-253') -H-Gamma-1 Anti-Cd3E (254'-707') [Vh Musmus/Homsap (Mus Musculus Ighv10-1*02 (92.9%) -(Ighd) -Ighj3*01 (100%)/Homo Sapiens Ighv3-73*01 (87.0%) -(Ighd) -Ighj6*01 (81.8%) T123>L (373'), S128>A (378'), Cdr-Imgt [8.10.16] (279'-286'.304'-313'.352'-367')) (254'-378')-Homo Sapiens Ighg1*03, G1M3, Ng1M1, Ch1 R120, Ch3 E12, M14, G1V14 Ch2 A1.3, A1.2, G1V33 Ch3 S22, A24, V86 (Hole), G1V83 Ch3 R115, F116 (Ch1 R120 (475') (379'-476'), Hinge 1-15 (477'-491'), Ch2 L1.3>A (495'), L1.2>A (496') (492'-601'), Ch3 E12 (617'), M14 (619'), T22>S (627'), L24>A (629'), Y86>V (686'), H115>R (696'), Y116>F (697') (602'-706'), Chs K2>Del (707')) (379'-707')]]; Dimer (485-487':488-490')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1, Glycoform Alfa
Small Cell Lung Carcinoma
Boehringer IngelheimP3BB (70)
Nogitecan
Small Cell Lung Carcinoma
AbbVieP4BB (70)
Serplulimab
Small Cell Lung Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,LtdP3BB (68)
Bl-M14D1
Small Cell Lung Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3BB (66)
Durvalumab
Small Cell Lung Carcinoma
PrECOG, LLC.P3BB (66)
Lurbinectedin
Small Cell Lung Carcinoma
Sichuan UniversityP3BB (66)
Tifcemalimab
Small Cell Lung Carcinoma
Sichuan UniversityP3BB (66)
Trilaciclib
Small Cell Lung Carcinoma
Pharmacosmos A/SP4BB (66)
Tuvonralimab
Small Cell Lung Carcinoma
The Second Affiliated Hospital of Dalian Medical UniversityP3BB (66)
al8326
Small Cell Lung Carcinoma
Advenchen Laboratories Nanjing Ltd.P3BB (65)
Atezolizumab
Small Cell Lung Carcinoma
Washington University School of MedicineP3BB (65)
Catequentinib
Small Cell Lung Carcinoma
Sun Yat-sen UniversityP4BB (65)
Iadademstat
Small Cell Lung Carcinoma
Yale UniversityP2BB (65)
Immunoglobulin G1-Kappa, Anti-[Fucosyl-Gm1 (Fucosylated Monosialoganglioside 1)], Homo Sapiens Monoclonal Antibody; H-Gamma1 Heavy Chain Homo Sapiens (1-452) [Vh (Homo Sapiens Ighv3-48*02 (90.7%) -(Ighd) -Ighj3*01 (92.3%) M123>T (117), Cdr-Imgt [8.8.15] (26-33.51-58.97-111)) (1-122) -Homo Sapiens Ighg1*03 (100%), G1M3, Ng1M1 Ch1 R120, Ch3 E12, M14 (Ch1 R120 (219) (123-220), Hinge 1-15 (221-235), Ch2 (236-345), Ch3 E12 (361), M14 (363) (346-450), Chs (451-452)) (123-452)], (225-214')-Disulfide With L-Kappa Light Chain Homo Sapiens (1'-214') [V-Kappa (Homo Sapiens Igkv1D-16*01 (100%) -Igkj4*01 (100%), Cdr-Imgt [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo Sapiens Igkc*01 (100%), Km3 A45.1 (153'), V101 (191') (108'-214')]; Dimer (231-231'':234-234'')-Bisdisulfide, Produced In A Chinese Hamster Ovary (Cho) Cell Line Lacking The Enzyme Alpha-(1,6)-Fucosyltransferase (Fut8), Glycoform Alfa
Small Cell Lung Carcinoma
Bristol-Myers SquibbP3BB (65)
Tarlatamab
Small Cell Lung Carcinoma
PrECOG, LLC.P3BB (65)
Tislelizumab
Small Cell Lung Carcinoma
BeOne MedicinesP4BB (65)
Adebrelimab
Small Cell Lung Carcinoma
Peking University Cancer Hospital & InstituteP3BB (64)
Irinotecan Hydrochloride Liposome
Small Cell Lung Carcinoma
Zhou ChengzhiP4BB (64)
Ivonescimab
Small Cell Lung Carcinoma
PrECOG, LLC.P3BB (64)
Niraparib
Small Cell Lung Carcinoma
ETOP IBCSG Partners FoundationP3BB (64)
Sugemalimab
Small Cell Lung Carcinoma
Peking University Cancer Hospital & InstituteP2/3BB (64)
Tiragolumab
Small Cell Lung Carcinoma
Hoffmann-La RocheP3BB (64)
Toripalimab
Small Cell Lung Carcinoma
Shanghai Best-Link Bioscience, LLCP3BB (64)
Chiauranib
Small Cell Lung Carcinoma
AkesoP3B (63)
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer
Small Cell Lung Carcinoma
Alliance Foundation Trials, LLC.P3B (63)
Rivoceranib
Small Cell Lung Carcinoma
Peking University Cancer Hospital & InstituteP3B (63)
Sorafenib
Small Cell Lung Carcinoma
Peking Union Medical College HospitalP2/3B (63)
Adriamycin
Small Cell Lung Carcinoma
Puma Biotechnology, Inc.P3B (62)
Cyclophosphamide
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P3B (62)
Lenvatinib
Small Cell Lung Carcinoma
Peking Union Medical College HospitalP2/3B (62)
Nivolumab
Small Cell Lung Carcinoma
Bristol-Myers SquibbP2B (62)
Olaparib
Small Cell Lung Carcinoma
University of CologneP3B (62)
Pembrolizumab
Small Cell Lung Carcinoma
GV20 TherapeuticsP3B (62)
pm8002
Small Cell Lung Carcinoma
Biotheus Inc.P3B (62)
Regorafenib
Small Cell Lung Carcinoma
Neonc Technologies, Inc.P2B (62)
zl-1310
Small Cell Lung Carcinoma
AmgenP3B (62)
Famitinib
Small Cell Lung Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2B (61)
Fludeoxyglucose
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P3B (61)
Ipilimumab
Small Cell Lung Carcinoma
Neonc Technologies, Inc.P3B (61)
Plinabulin
Small Cell Lung Carcinoma
Xiaorong DongP2B (61)
Vinorelbine Ditartrate
Small Cell Lung Carcinoma
Central European Society for Anticancer Drug ResearchP2B (61)
Showing 1 to 50 of 277 assets
PreviousPage 1 of 6Next